TransMedics Earns Second PMA For OCS Lung System

FDA approved a PMA supplement to allow TransMedics' Organ Care System (OCS) to be used for the preservation and ex-vivo assessment of lungs that would not be acceptable for transplant if they had been preserved with a standard cold static system.

MT1906_human-lungs_98111591_1200.jpg
• Source: shutterstock.com

More from Approvals

More from Policy & Regulation